Who owns the TISSUE-SPECIFIC THERAPEUTICS (TSTX) trademark?

The TISSUE-SPECIFIC THERAPEUTICS (TSTX) trademark is owned by Immix Biopharma, Inc..

What class is the TISSUE-SPECIFIC THERAPEUTICS (TSTX) trademark registered in?

The TISSUE-SPECIFIC THERAPEUTICS (TSTX) trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for TISSUE-SPECIFIC THERAPEUTICS (TSTX)?

The USPTO serial number for TISSUE-SPECIFIC THERAPEUTICS (TSTX) is 90816280.

What is the registration number for TISSUE-SPECIFIC THERAPEUTICS (TSTX)?

TISSUE-SPECIFIC THERAPEUTICS (TSTX) is registered under USPTO registration number 0.

TIS

USPTO Trademark Record

ABANDONED

TISSUE-SPECIFIC THERAPEUTICS (TSTX)

SN 90816280·Reg 0·Filed Jul 07, 2021

Owner Immix Biopharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

TISSUE-SPECIFIC THERAPEUTICS (TSTX) (Serial No. 90816280), Registration No. 0, is a abandoned US trademark filed on Jul 07, 2021 by Immix Biopharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

TISSUE-SPECIFIC THERAPEUTICS (TSTX) (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jul 07, 2021

SERIAL

90816280

REG#

Owner

Applicant

Immix Biopharma, Inc.

Entity

Corporation

State

Address

10573 W. Pico Blvd, Los Angeles, CA, 90064

Country

Attorney

NameSheila R. Gibson

Law firm

Sheila R. Gibson Aura IP Law

Docket

IMX-007UT

Address

3217 Carson Street #294, Lakewood, CA 90712, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJul 07, 2021

Serial Number90816280

Registration No.0

Status DateMay 04, 2024

Mark TypeStandard characters

Attorney DocketIMX-007UT

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

May 04, 2024

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

May 04, 2024

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jan 16, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jan 16, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION WRITTEN

Oct 14, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 14, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 14, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO LIE

Nov 10, 2022

ASSIGNED TO LIE

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 10, 2022

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 10, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 10, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 28, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 29, 2022

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 29, 2022

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 29, 2022

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NON-FINAL ACTION WRITTEN

Mar 28, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 28, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 28, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 24, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 15, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 10, 2021

NEW APPLICATION ENTERED

TISSUE-SPECIFIC THERAPEUTICS (TSTX)

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Immix Biopharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Sheila R. Gibson

Resources

Company